Skip to main content

Table 6 Vac-1 group: proportions of VAHL reports in age groups segmented using CHAID algorithm (Pv < 0.01)

From: Hypermetabolic lymphadenopathy following administration of BNT162b2 mRNA Covid-19 vaccine: incidence assessed by [18F]FDG PET-CT and relevance to study interpretation

  <62.07 (n = 93) >62.07 (n = 218) Pv
No HLN 53 (57.0%) 167 (76.6%) <0.01
Grade 1 VAHL 15 (16.1%) 25 (11.5%) 0.26
Grade 2 VAHL 17 (18.3%) 23 (10.6%) 0.06
Grade 3 VAHL 5 (5.4%) 2 (0.9%) 0.03
Grade 4 VAHL 3 (3.2%) 1 (0.5%) 0.08
  1. Categorical variables are reported as frequency and percentage